SIC
PFE icon

Samalin Investment Counsel’s Pfizer PFE Stock Holding History

Samalin Investment Counsel’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$621K Sell
25,787
-1,126
-4% -$29.5K 0.19% 133
2026
Q1 		$756K Buy
26,913
+2,246
+9% +$59.8K 0.27% 110
2025
Q4 		$614K Sell
24,667
-1,392
-5% -$35.1K 0.22% 137
2025
Q3 		$664K Sell
26,059
-4,215
-14% -$104K 0.23% 128
2025
Q2 		$734K Buy
30,274
+657
+2% +$15.3K 0.28% 103
2025
Q1 		$751K Buy
29,617
+4,199
+17% +$110K 0.3% 97
2024
Q4 		$674K Buy
25,418
+605
+2% +$16.4K 0.29% 102
2024
Q3 		$718K Buy
24,813
+4,531
+22% +$132K 0.31% 94
2024
Q2 		$568K Buy
20,282
+1,025
+5% +$28.2K 0.27% 121
2024
Q1 		$534K Buy
19,257
+584
+3% +$16.2K 0.25% 127
2023
Q4 		$538K Buy
18,673
+7,361
+65% +$223K 0.27% 117
2023
Q3 		$375K Buy
11,312
+862
+8% +$30.5K 0.22% 143
2023
Q2 		$383K Buy
10,450
+37
+0.4% +$1.44K 0.21% 138
2023
Q1 		$425K Sell
10,413
-713
-6% -$30.8K 0.26% 116
2022
Q4 		$570K Sell
11,126
-546
-5% -$26.2K 0.36% 83
2022
Q3 		$511K Buy
11,672
+791
+7% +$38.4K 0.37% 78
2022
Q2 		$571K Buy
10,881
+33
+0.3% +$1.68K 0.4% 67
2022
Q1 		$562K Sell
10,848
-477
-4% -$24.8K 0.34% 82
2021
Q4 		$669K Buy
11,325
+339
+3% +$16.8K 0.4% 67
2021
Q3 		$472K Buy
10,986
+385
+4% +$17.1K 0.31% 102
2021
Q2 		$415K Buy
10,601
+43
+0.4% +$1.67K 0.27% 122
2021
Q1 		$382K Buy
10,558
+426
+4% +$15.1K 0.26% 123
2020
Q4 		$373K Sell
10,132
-22
-0.2% -$807 0.28% 116
2020
Q3 		$354K Buy
10,154
+40
+0.4% +$1.4K 0.32% 103
2020
Q2 		$313K Buy
10,114
+2,360
+30% +$80.2K 0.33% 100
2020
Q1 		$240K Sell
7,754
-10
-0.1% -$341 0.32% 97
2019
Q4 		$288K Buy
+7,764
New +$277K 0.24% 115

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Samalin Investment Counsel's PFE Position: Q2 2026 in Review

Samalin Investment Counsel reduced its Pfizer (PFE) stake by 4.2% in Q2 2026, selling an estimated $29.5K and leaving 25,787 shares worth $621K. The position accounts for 0.19% of the portfolio, ranked #133.

Samalin Investment Counsel first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $756K in Q1 2026. 1,179 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Samalin Investment Counsel held 25,787 shares of Pfizer worth $621K as of Q2 2026.
  • Samalin Investment Counsel sold 1,126 Pfizer shares in Q2 2026, an estimated $29.5K.
  • Pfizer made up 0.19% of Samalin Investment Counsel's portfolio in Q2 2026, its #133 holding.
  • Samalin Investment Counsel first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
  • Samalin Investment Counsel's Pfizer position peaked at $756K in Q1 2026.
  • 1,179 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Samalin Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.